Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Emilia Montagna"'
Autor:
Francesca Magnoni, Giovanni Corso, Patrick Maisonneuve, Beatrice Bianchi, Giuseppe Accardo, Claudia Sangalli, Giulia Massari, Anna Rotili, Luca Nicosia, Filippo Pesapane, Emilia Montagna, Giovanni Mazzarol, Viviana Galimberti, Paolo Veronesi, Giuseppe Curigliano
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102552- (2024)
Summary: Background: Abemaciclib is currently approved for the adjuvant treatment of high-risk, lymph node (LN)-positive, hormone receptor (HR)-positive breast cancer (BC). In a real-world setting the clinicopathologic features of patients potentiall
Externí odkaz:
https://doaj.org/article/5a1c411c7ade4845974d93f55c272de9
Autor:
Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, Vincenzo Bagnardi, Eleonora Pagan, Emilia Montagna, Giuseppe Cancello, Raffaella Ghisini, Claudia Sangalli, Mara Negri, Manuelita Mazza, Monica Iorfida, Anna Cardillo, Angela Sciandivasci, Nadia Bianco, Ana Paula De Maio, Monica Milano, Giuseppe Maria Campennì, Loredana Sansonno, Giuseppe Viale, Anna Morra, Maria Cristina Leonardi, Viviana Galimberti, Paolo Veronesi, Marco Colleoni
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5167-5178 (2021)
Background: Adjuvant chemotherapy for Luminal B-like breast cancers usually includes anthracycline-based regimens. However, some patients are reluctant to receive chemotherapy because of side-effects, especially alopecia, and ask for a “less intens
Externí odkaz:
https://doaj.org/article/01c8698cc532419a944449afa4337d24
Autor:
Fabio Conforti, Laura Pala, Eleonora Pagan, Elena Guerini Rocco, Vincenzo Bagnardi, Emilia Montagna, Giulia Peruzzotti, Tommaso De Pas, Caterina Fumagalli, Silvana Pileggi, Chiara Pesenti, Sergio Marchini, Giovanni Corso, Caterina Marchio’, Anna Sapino, Rossella Graffeo, Laetitia Collet, Philippe Aftimos, Christos Sotiriou, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Marco Colleoni, Aron Goldhirsch
Publikováno v:
Breast, Vol 59, Iss , Pp 94-101 (2021)
Background: We report here for the first time, a comprehensive characterization of biological and clinical features of early-stage triple negative Invasive Lobular Carcinomas(TN-ILCs) Methods: We analyzed all consecutive patients with early-stage TN-
Externí odkaz:
https://doaj.org/article/0e41cdfb84f743128a8f6f2c40685bb2
Autor:
Greta Caprara, Maria Tieri, Alessandra Fabi, Valentina Guarneri, Cristina Falci, Maria Vittoria Dieci, Monica Turazza, Bettina Ballardini, Alessandra Bin, Saverio Cinieri, Patrizia Vici, Emilia Montagna, Claudio Zamagni, Cristina Mazzi, Alessandra Modena, Fabiana Marchetti, Matteo Verzè, Francesca Ghelfi, Lucilla Titta, Fabrizio Nicolis, Stefania Gori
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/176d2606f40445588b7a7e41c90135f1
Autor:
Emilia Montagna, Giuseppe Cancello, Eleonora Pagan, Vincenzo Bagnardi, Elisabetta Munzone, Silvia Dellapasqua, Giuseppe Viale, Giovanni Mazzarol, Paolo Veronesi, Viviana Galimberti, Giorgia Santomauro, Marco Colleoni
Publikováno v:
Breast, Vol 53, Iss , Pp 138-142 (2020)
Background: Triple negative breast cancer encompasses several biological entities with different outcomes and is a priority to identify which patients require more treatment to reduce the risk of recurrence and which patients need less treatment. Pat
Externí odkaz:
https://doaj.org/article/0ffe5f3db11e4874a981ef6874bbfb58
Autor:
Greta Caprara, Maria Tieri, Alessandra Fabi, Valentina Guarneri, Cristina Falci, Maria Vittoria Dieci, Monica Turazza, Bettina Ballardini, Alessandra Bin, Saverio Cinieri, Patrizia Vici, Emilia Montagna, Claudio Zamagni, Cristina Mazzi, Alessandra Modena, Fabiana Marchetti, Matteo Verzè, Francesca Ghelfi, Lucilla Titta, Fabrizio Nicolis, Stefania Gori
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The role of a healthy diet in cancer prevention is well recognized. Recent data indicate that following the same advices can also improve cancer survivors’ quality of life. Breast cancer (BC) patients are commonly concerned about diet and nutrition
Externí odkaz:
https://doaj.org/article/eb3296ead24640c9920820e375b39999
Autor:
Emilia Montagna, Marco Colleoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Approximately 50% of HER2 positive breast cancer cases are also estrogen receptor (ER) positive. Data supports a role for close cross-talk between the ER and HER2 signaling pathways as an important contributor to the development of de novo or acquire
Externí odkaz:
https://doaj.org/article/ee41fd56841945ef8f70980c73b57ef9
Autor:
Aeson Chang, Edoardo Botteri, Ryan D. Gillis, Lukas Löfling, Caroline P. Le, Alexandra I. Ziegler, Ni-Chun Chung, Matthew C. Rowe, Stewart A. Fabb, Brigham J. Hartley, Cameron J. Nowell, Sasagu Kurozumi, Sara Gandini, Elisabetta Munzone, Emilia Montagna, Nina Eikelis, Sarah E. Phillips, Chikako Honda, Kei Masuda, Ayaka Katayama, Tetsunari Oyama, Steve W. Cole, Gavin W. Lambert, Adam K. Walker, Erica K. Sloan
Publikováno v:
Science Translational Medicine. 15
Beta-adrenergic blockade has been associated with improved cancer survival in patients with triple-negative breast cancer (TNBC), but the mechanisms of these effects remain unclear. In clinical epidemiological analyses, we identified a relationship b
Autor:
Rebecca Salvatori, Marco Manzoni, Daniela Lepanto, Viviana Stufano, Simona Pessina, Chiara Zanetti, Fabio Bassi, Giovanni Mazzarol, Emilia Montagna, Fausto Maffini
Publikováno v:
Tumori Journal. 109:197-202
Background: Very little is currently known about molecular alteration of matrix-producing carcinoma of the breast. However, the morphological similarity with other neoplasm with a myxo-chondroid component is remarkable. In this pilot study we evaluat
Autor:
Francesca Colombo, Emilia Montagna, Laura Lavinia Travaini, Cristiana Fodor, Eliana La Rocca, Mattia Zaffaroni, Maria Cristina Leonardi, Paolo Veronesi, Samantha Dicuonzo, Sabrina Kahler-Ribeiro-Fontana, Barbara Alicja Jereczek-Fossa, Roberto Orecchia, Damaris Patricia Rojas, Sara Gandini, Giovanni Mazzarol, Anna Morra, Stefania Volpe, C. Arrobbio, Marco Colleoni, Viviana Galimberti, M.A. Zerella
Publikováno v:
Radiotherapy and Oncology. 163:128-135
Aim To assess the rate of positive non-sentinel lymph nodes (non-SLNs) after neoadjuvant systemic therapy (NAST) in breast cancer (BC) following positive sentinel lymph node biopsy (SLNB). Materials and methods From institutional database, 265 consec